Worldwide News

By Akash Bhattacharya, Senior Application Scientist at Beckman Coulter Life Sciences Gene therapy holds enormous potential to cure and prevent a range of diseases, from inherited disorders to cancers to viral infections. The first gene therapy product was approved by the Food and Drug Administration in the US in 2017, and since then, approvals have […]

Dr J. Mark Treherne, Dr Christian Pernstich and Dr Michael Jones examine how the controlled release of proteins will  improve the reproducibility of cell-based drug discovery screens? Cell-based screening systems are now routinely incorporated as pivotal decision-making assays much earlier into the drug discovery process across most therapeutic areas and increasingly so for more complex […]

Eurofins Discovery is a CRO with a range of expertise in drug discovery. Christina Shasserre, Senior VP spoke to Lu Rahman about some of the company’s current COVID-related work as well as offering insight into the drug discovery landscape.   LR: Are you able to share some of Eurofins Discovery’s recent projects? CS: As we […]

DNA synthesis company Twist Bioscience has developed a revolutionary, silicon-based approach to building synthetic DNA. By miniaturising chemistry, and maximising synthesis throughout, it has ramped up the availability and accessibility of synthetic DNA for the biotech and biopharma industries. Lu Rahman chatted with Twist co-founder and CEO Emily Leproust about its path to success.   […]

Dr Lotfi Chouchane and Dr. Javaid Sheikh, Weill Cornell Medicine-Qatar, outline the challenges and opportunities ahead for drug discovery Precision medicine is an emerging model for the next generation of clinical care that will capitalise on the dynamic interaction between individual biology, lifestyle, behaviour, and environment. It holds huge promise for healthcare and the drug […]

CN Bio is a cell culture company whose mission is to transform the way human-relevant pre-clinical data is generated by developing the most complete model of the human ‘body-on-a-chip’ in the laboratory.  Achieving this is what drives the company’s future initiatives, CEO Dr David Hughes told Lu Rahman. CN Bio hit its first major milestone […]

Traditional approaches for vaccine discovery and development are being reimagined and accelerated – leveraging technologies in novel ways to streamline workflows and forging collaborations. Dr. Sanjay Garg and Dr. Anis H Khimani, discuss key learnings and best practices during COVID-19 vaccine research and how we can take these forward to pathogens yet unknown. Typically, it […]

Capable of boasting high-throughput, accurate, multiparameter and highly reproducible results, Urmi Roy, Global Product Manager Miltenyi Biotec outlines the benefits of flow cytometry offering case study examples for its use. Increasing numbers of drug discovery programmes are targeting cellular mechanism and phenotype as a promising avenue for new therapies. The clinical motivation behind this is […]

Sam Cooper founded Phenomic AI in 2017 alongside Oren Kraus, as an early stage biotech company seeking to commercialise AI approaches for pharmaceutical R&D. He discusses the role of AI in drug discovery with Lu Rahman. LR: Where are we with deep learning and drug discovery and how effective is it for researchers? How well […]

Sebastian Nijman, Chief Scientific Officer, Scenic Biotech, explains why harnessing genetic modifiers holds great potential to address the present drug target vacuum and why every drug developer should care about them. According to the National Institute of Health (NIH), approximately 500 of the many thousands of human diseases have an approved treatment. This disappointing result is […]